Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Cellectar Biosciences, Inc. (CLRB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $10.54 per share as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2017-11-09
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $10.54.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $16.31.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $19.84.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $26.68.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2017-09-30 | $10.54 10-Q · filed 2017-11-09 |
| 2017-06-30 | $16.31 10-Q · filed 2017-08-14 |
| 2017-03-31 | $19.84 10-Q · filed 2017-05-11 |
| 2016-12-31 | $26.68 10-K · filed 2017-03-15 |
| 2016-09-30 | $64.84 10-Q · filed 2016-11-10 |
| 2016-06-30 | $121.37 10-Q · filed 2016-08-11 |
| 2016-03-31 | $166.14 10-Q · filed 2016-05-12 |
| 2015-12-31 | $180.70 10-K/A · filed 2016-10-20 |
| 2015-09-30 | $18.04 10-Q · filed 2015-11-12 |
| 2015-06-30 | $18.14 10-Q · filed 2015-08-12 |
| 2015-03-31 | $22.84 10-Q · filed 2015-05-20 |
| 2014-12-31 | $24.53 10-K · filed 2015-05-20 |
| 2014-09-30 | $27.98 10-Q · filed 2015-05-20 |
| 2014-06-30 | $29.00 10-Q · filed 2014-08-04 |
| 2014-03-31 | $1.51 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.55 10-K · filed 2014-03-19 |
| 2013-09-30 | $1.96 10-Q · filed 2013-11-13 |
| 2013-06-30 | $2.12 10-Q · filed 2013-08-12 |
| 2013-03-31 | $2.33 10-Q · filed 2013-05-15 |
| 2012-12-31 | $2.63 10-K · filed 2013-03-28 |
| 2012-09-30 | $2.92 10-Q · filed 2012-11-06 |
| 2012-06-30 | $3.37 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |